|
|
|
|
||
Re: Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP)At a minimum, I don't see them as a threat in the next 2-3 years. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
46239 | Re: Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP) | justarook04 | 1 | 6/13/2019 8:47:50 AM |